IMAGO BIOSCIENCES INC's ticker is and the CUSIP is 45250K107. A total of 1 filers reported holding IMAGO BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $399 | – | 11,100 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,018,737 | $40,421,000 | 12.90% |
Frazier Life Sciences Management, L.P. | 2,971,274 | $39,785,000 | 3.76% |
StepStone Group LP | 522,987 | $7,003,000 | 0.75% |
Parkman Healthcare Partners LLC | 147,387 | $1,974,000 | 0.73% |
EMERALD ADVISERS, LLC | 823,062 | $11,021,000 | 0.57% |
EMERALD MUTUAL FUND ADVISERS TRUST | 699,986 | $9,373,000 | 0.54% |
Regency Capital Management Inc.\DE | 18,050 | $242,000 | 0.26% |
FARALLON CAPITAL MANAGEMENT LLC | 2,471,313 | $33,091,000 | 0.18% |
Woodline Partners LP | 672,060 | $8,999,000 | 0.14% |
AlpInvest Partners B.V. | 30,156 | $404,000 | 0.14% |